Perseus
 


PORTFOLIO COMPANIES

Rosetta Inpharmatics, Inc.

Rosetta Inpharmatics, Inc. – Realized

Rosetta Inpharmatics, a developer of new technologies for drug discovery that allow high-throughput screening of potential therapeutic compounds for their effects on cells, was sold to Merck in May 2001.

© 2001-11 PERSEUS, L.L.C., Designer: Beebe Comm. Updated 10/12/12
Photo Credits: Bridgeman Art Library and Art Resource.